Meet Synthace's interdisciplinary team of computer scientists, biologists, mathematicians, and chemists.
Board of Directors
Bob Wiederhold | Chairman
Bob holds the position of Executive Chairman at Couchbase and previously served as President and Chief Executive Officer at Couchbase from 2010 to 2017. Prior to Couchbase, Bob was chairman, CEO, and president of Transitive Corporation, the worldwide leader in cross-platform virtualization with over 20 million users, until it was acquired by IBM in 2008. Before Transitive, he was president and CEO of Tality Corporation, the worldwide leader in electronic design services, whose revenues and size grew to almost $200 million and had 1,500 worldwide employees.
Bob held several executive general management positions at Cadence Design Systems, Inc., an electronic design automation company, which he joined in 1985 as an early stage startup and helped to grow to more than $1.5 billion during his 13 years at the company. Bob also headed High Level Design Systems, a successful electronic design automation startup that was acquired by Cadence in 1996. Bob holds a bachelor’s degree in Electrical Engineering from University of Massachusetts Amherst and a master’s from Cornell University in Electrical Engineering.
Tim Fell | Chief Executive Officer
Tim is an experienced technology venture entrepreneur with an R&D background in both the physical and life sciences. Before joining Synthace he spent 7 years as Chief Operating Officer of CellCentric, a leading epigenetics drug discovery company. Prior to that he was Chief Technology Officer of Arrow Therapeutics and was co-founder and General Manager of DNA microarray tools company Oxford Gene Technology (Operations).
Before entering the commercial world Tim spent 13 years performing highly interdisciplinary research at the University of Oxford holding post-doctoral positions in three different departments (Biochemistry, Engineering and Materials). He has a D.Phil in Semiconductor Materials and an MBA from London Business School.
Tim is the Chairman of the UK BioIndustry Association’s Engineering Biology Advisory Committee and also a member of the Synthetic Biology Leadership Council co-chaired by The Rt Hon Lord Henley, Parliamentary Under Secretary of State at the Department for Business, Energy and Industrial Strategy.
Sean Ward | Chief Technology Officer
Before founding Synthace, Sean was a Research Associate in Bioinformatics at University College London, where he conducted research into protein folding, protein structure prediction, and gene coding. Prior to his work in bioinformatics, Sean was the Co-Founder and CTO of Relatable, a leading US-based acoustic fingerprinting company, whose customers included major peer to peer companies such as Napster, as well as consumer electronics manufacturers, royalty collection agencies, and major labels. Sean has a BSc in Computer Science from UCL.
Isabel Fox | Non-executive Director
Isabel Fox is the Head of Venture Capital at White Cloud, investing predominantly in healthcare and education start-ups in Europe, Asia and Australasia. She started out in finance, followed by financial PR (tech IPOs) before founding two corporate/tech PR firms. She was also a part of the founding team of two software start-ups and an active investor in the UK and US.
Izzy is an advisor and angel investor in several start-ups including Adbrain, Jumio, BitPay, Get Around, Violin Memory, Tray.io, Cloud House, GetCrane and more. As an INN graduate, her passion is health and wellbeing and shaping the future of healthcare.
Joško Bobanovic | Non-executive Director
Joško joined Sofinnova in 2010 as Partner of the Sofinnova Green Seed Fund dedicated to seed activities in renewable chemistry and bio-energy. Prior to joining Sofinnova, he spent eight years in venture capital with iNovia Capital and its fund MSBi Capital in Montreal, Canada. Joško was responsible for cleantech investments at the fund and focused on seed and early-stage investments in cleantech and information technology.
Prior to his venture capital career, he created an internet start-up and a software company. After completing his PhD studies Jou0161ko developed real-time ocean forecasting systems still used at Environment Canada for coastal ocean management. Jou0161ko holds a BSc. in physics from the University of Zagreb, a PhD in physical oceanography from Dalhousie University and an MBA in finance and marketing from McGill University.
Bill Liao | Non-executive Director
Bill works as the European Investment Partner at SOSventures, supporting and mentoring startups at all stages of growth, with a special emphasis on the Synbio Accelerator program. Bill has a wealth of experiences, both in the public and private sectors. A co-founder of CoderDojo, a free global network formed to assist young people with learning computer programming, Bill also co-founded XING, a pioneering enterprise social networking platform.
Prior to these endeavours, Bill served as COO of Davnet, a telecommunications carrier. Bill has also distinguished himself as a diplomat, serving as a special diplomatic envoy for St Kitts and Nevis, with an emphasis on sustainable development and the environment. Author of three books, he is a regular speaker at many events and venues such as The London School of Economics, The World Economic Forum, The Globe Forum in Sweden, The House of Commons and TED as well as TEDx. He is Founder of WeForest that has planted over 5 million trees globally.
Markus Gershater | Chief Scientific Officer
Markus co-founded Synthace after working as a Research Associate in Synthetic Biology at University College London where he developed novel biosynthesis methods using pathway engineering. Prior to UCL, he was a Biotransformation Scientist at Novacta Biosystems working as part of the industrial biotechnology group that conducted more than 90 contract research projects for over 20 clients. Markus has a PhD in Plant Biochemistry from Durham.
Michael Sadowski | Head of Bioinformatics
Dr Sadowski (usually called Sid) is a passionate and enthusiastic computational biologist of some 15 years’ standing with a background in protein sequence, structure and function analysis. His life in bioinformatics started at Leeds with Dave Westhead and J. Howard Parish, followed by postdocs at UCL and NIMR with David Jones and Willie Taylor.
Mark Watson | Chief Commercial Officer
Mark has a proven track record of growing numerous companies into hundred million dollar businesses. Mark developed his flair for execution through his experience of working for blue chip companies and serving as a non-executive director on a number of boards.
Prior to joining Synthace, he held senior positions at a number of top firms including, Siemens, Logica, Midland Montagu, Oracle, Micromuse, Axiom and Sage. He was also a founding partner of a leading sales acceleration consultancy. As well as being a trained accountant, Mark is a fully-qualified member of Chartered Institute of Marketing (MCIM) and holds a first class degree in Industrial Management.